Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials.

Frederick Berro RiveraNathan Ross B BantayanJohn Paul ApareceLinnaeus Louisse A CruzJohn Vincent MagallongPolyn Luz PineAnne Mira Nicca Idian-JavierGrace Nooriza O LumbangEdgar V LermaKyla M Lara-BreitingerMartha GulatiKrishnaswami Vijayaraghavan

Published in: Journal of clinical lipidology (2024)

Significant reductions in MACE with GLP-1RA treatment were demonstrated between both sexes and across certain ethnicities and certain geographical regions.

Keyphrases

randomized controlled trial
placebo controlled
rheumatoid arthritis
double blind
study protocol
emergency department
squamous cell carcinoma
healthcare
clinical trial
type diabetes
combination therapy
phase ii
systemic lupus erythematosus
adipose tissue
adverse drug
skeletal muscle
meta analyses